Effects of N-acetylcysteine on nicotinamide dinucleotide phosphate oxidase activation and antioxidant status in heart, lung, liver and kidney in streptozotocin-induced diabetic rats

Yonsei Medical Journal

Volumn 53, Issue 2, 2012, Pages 294-303

  Lei, Shaoqing ^a,b   Liu, Yanan ^b   Liu, Huimin ^b   Yu, Hong ^a   Wang, Hui ^a   Xia, Zhengyuan ^a,b  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antioxidant status; Diabetes; N acetylcysteine; NADPH oxidase

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ISOPROSTANE DERIVATIVE; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; HEART; IMMUNOBLOTTING; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PLASMA; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

EID: 84863138767     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.2.294     Document Type: Article

References (48)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362: 1090-1101.
2. Hakim FA, Pfueger A. Role of oxidative stress in diabetic kidney disease. Med Sci Monit 2010;16:RA37-RA48.
3. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48:1-9.
4. Ceriello A, Testa R. Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care 2009;32 Suppl 2:S232-S236.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
6. Robinson I, de Serna DG, Gutierrez A, Schade DS. Vitamin E in humans: an explanation of clinical trial failure. Endocr Pract 2006;12:576-582.
7. Hasnain BI, Mooradian AD. Recent trials of antioxidant therapy: what should we be telling our patients? Cleve Clin J Med 2004; 71:327-334.
8. Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009;106:8665-8670.
9. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 2009;82:9-20.
10. Shen GX. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase. Can J Physiol Pharmacol 2010;88:241-248.
11. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006;21:269-280.
12. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
13. Liu S, Ma X, Gong M, Shi L, Lincoln T, Wang S. Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med 2007;42:852-863.
14. Li L, Renier G. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothe-lial growth factor expression. Metabolism 2006;55:1516-1523.
15. Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, et al. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006;99: 69-77.
16. Guo Z, Xia Z, Jiang J, McNeill JH. Downregulation of NADPH oxidase, antioxidant enzymes, and infammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cyste-ine. Am J Physiol Heart Circ Physiol 2007;292:H1728-H1736.
17. Sandström J, Nilsson P, Karlsson K, Marklund SL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 1994;269:19163-19166.
18. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625.
19. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Oph-thalmol Vis Sci 2006;47:1594-1599.
20. Madsen-Bouterse SA, Zhong Q, Mohammad G, Ho YS, Kowluru RA. Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic Res 2010;44:313-21.
21. Reis JS, Bosco AA, Veloso CA, Mattos RT, Purish S, Nogueira-Machado JA. Oxidizing and reducing responses in type 1 diabetic patients determined up to 5 years after the clinical onset of the disease. Acta Diabetol 2008;45:221-224.
22. Ivanović-Matić S, Mihailović M, Dinić S, Martinović V, Bogojević D, Grigorov I, et al. The absence of cardiomyopathy is accompanied by increased activities of CAT, MnSOD and GST in long-term diabetes in rats. J Physiol Sci 2010;60:259-266.
23. Ghosh S, Pulinilkunnil T, Yuen G, Kewalramani G, An D, Qi D, et al. Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion. Am J Physiol Heart Circ Physiol 2005;289:H768-H776.
24. Yue KK, Chung WS, Leung AW, Cheng CH. Redox changes precede the occurrence of oxidative stress in eyes and aorta, but not in kidneys of diabetic rats. Life Sci 2003;73:2557-2570.
25. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hy-droxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
26. Xia Z, Kuo KH, Nagareddy PR, Wang F, Guo Z, Guo T, et al. N-acetylcysteine attenuates PKCbeta2 overexpression and myocar-dial hypertrophy in streptozotocin-induced diabetic rats. Cardio-vasc Res 2007;73:770-782.
27. Meng X, Tancharoen S, Kawahara KI, Nawa Y, Taniguchi S, Hashiguchi T, et al. 1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from infammatory reactions. Int J Immunopathol Pharmacol 2010;23:105-119.
28. Xu M, Dai DZ, Zhang Q, Cheng YS, Dai Y. Upregulated NADPH oxidase contributes to diabetic testicular complication and is relieved by strontium fructose 1,6-diphosphate. Exp Clin Endocrinol Diabetes 2010;118:459-465.
29. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, et al. Urinary 15-F2t-isoprostane, afatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcino-genesis 2008;29:971-976.
30. Faure P, Polge C, Monneret D, Favier A, Halimi S. Plasma 15-F2t isoprostane concentrations are increased during acute fructose loading in type 2 diabetes. Diabetes Metab 2008;34:148-154.
31. Mandal CC, Ganapathy S, Gorin Y, Mahadev K, Block K, Ab-boud HE, et al. Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. Bio-chem J 2011;433:393-402.
32. Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 2005;26:908-917.
33. Du D, Shi YH, Le GW. Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. Mol Biol Rep 2010;37:3833-3839.
34. Ahmed FN, Naqvi FN, Shafiq F. Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus. Ann N Y Acad Sci 2006;1084:481-489.
35. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008;45:41-46.
36. Hünkar T, Aktan F, Ceylan A, Karasu C; Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin-diabetic rats. Cell Biochem Funct 2002;20:297-302.
37. Olukman M, Orhan CE, Celenk FG, Ulker S. Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. J Diabetes Complications 2010;24:415-423.
38. Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, et al. Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci 2002;959:199-213.
39. Fosslien E. Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 2001;31:25-67.
40. Sack MN. Type 2 diabetes, mitochondrial biology and the heart. J Mol Cell Cardiol 2009;46:842-849.
41. Kowluru RA, Kowluru V, Xiong Y, Ho YS. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med 2006;41:1191-1196.
42. Hotamisligil GS. Endoplasmic reticulum stress and the infamma-tory basis of metabolic disease. Cell 2010;140:900-917.
43. Casas-Agustench P, Bulló M, Salas-Salvadó J. Nuts, infammation and insulin resistance. Asia Pac J Clin Nutr 2010;19:124-130.
44. Navarro-Gonzalez J, Mora-Fernandez C, Gomez-Chinchon M, Muros M, Herrera H, Garcia J. Serum and gene expression profle of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration. Int J Immu-nopathol Pharmacol 2010;23:51-59.
45. Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z. The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol 2010. [Epub ahead of print]
46. Tsai GY, Cui JZ, Syed H, Xia Z, Ozerdem U, McNeill JH, et al. Effect of N-acetylcysteine on the early expression of infammatory markers in the retina and plasma of diabetic rats. Clin Experiment Ophthalmol 2009;37:223-231.
47. Palacio JR, Markert UR, Martínez P. Anti-infammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Infamm Res 2011;60:695-704.
48. Nascimento MM, Suliman ME, Silva M, Chinaglia T, Marchioro J, Hayashi S Y, et al. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int 2010; 30:336-342.